Atlas Trials

Phase 1 Study of ATR-002

Clinical trial NCT04385420 · COMPLETED

Trial details

NCT number
NCT04385420
Sponsor
Atriva Therapeutics GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Influenza
Start date
2019-04-24
Primary completion
2019-08-26
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.